Not Yet RecruitingNot Applicable

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

United States400 participantsStarted 2026-06-01

Plain-language summary

All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.

Who can participate

Age range25 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Women aged 25 - 49 years
✓. women undergoing cervical biopsy and/or LEEP
✓. Women who are not pregnant and with a negative pregnancy test (within 3 days of enrollment)
✓. Willing and capable of providing informed consent

Exclusion criteria

✕. Women under 25 or over 49 years of age
✕. Women not undergoing cervical biopsy or LEEP
✕. Women who are pregnant

What they're measuring

Primary Out Measures

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06850402

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09-01

Contact for this trial

Kathleen M Schmeler, MD

(713) 854-9150 kschmele@mdanderson.org

View on ClinicalTrials.gov More Cervical Cancer trials